- Home
- CGEN vs OGI Comparison
CGEN vs OGI Comparison
Compare CGEN & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGEN | OGI |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | Israel | Canada |
| Employees | N/A | 1137 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.1M | 171.3M |
| IPO Year | 2001 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CGEN | OGI |
|---|---|---|
| Price | $2.62 | $1.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 345.5K | ★ 1.0M |
| Earning Date | 05-18-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.10 |
| Revenue Next Year | $75.09 | $13.92 |
| P/E Ratio | ★ N/A | $13.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $0.85 |
| 52 Week High | $3.24 | $2.24 |
Technical Indicators
Market Signals| Indicator | CGEN | OGI |
|---|---|---|
| Relative Strength Index (RSI) | 60.10 | 61.75 |
| Support Level | $2.54 | $1.18 |
| Resistance Level | $3.05 | $1.69 |
| Average True Range (ATR) | 0.13 | 0.06 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 63.78 | 52.50 |
Price Performance
Historical ComparisonAbout CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.